MacroGenics Net Profit Margin 2012-2024 | MGNX
MacroGenics net profit margin from 2012 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
| MacroGenics Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2024-03-31 | $0.04B | $-0.02B | -53.49% |
| 2023-12-31 | $0.06B | $-0.01B | -15.52% |
| 2023-09-30 | $0.12B | $0.05B | 41.67% |
| 2023-06-30 | $0.15B | $0.01B | 4.61% |
| 2023-03-31 | $0.17B | $-0.09B | -55.15% |
| 2022-12-31 | $0.15B | $-0.12B | -78.29% |
| 2022-09-30 | $0.09B | $-0.19B | -204.30% |
| 2022-06-30 | $0.07B | $-0.22B | -325.37% |
| 2022-03-31 | $0.07B | $-0.22B | -301.39% |
| 2021-12-31 | $0.08B | $-0.20B | -258.97% |
| 2021-09-30 | $0.12B | $-0.15B | -124.79% |
| 2021-06-30 | $0.12B | $-0.13B | -108.40% |
| 2021-03-31 | $0.11B | $-0.14B | -125.93% |
| 2020-12-31 | $0.11B | $-0.13B | -123.81% |
| 2020-09-30 | $0.08B | $-0.16B | -205.19% |
| 2020-06-30 | $0.08B | $-0.17B | -214.10% |
| 2020-03-31 | $0.07B | $-0.15B | -220.29% |
| 2019-12-31 | $0.07B | $-0.15B | -233.85% |
| 2019-09-30 | $0.06B | $-0.17B | -298.21% |
| 2019-06-30 | $0.06B | $-0.16B | -268.97% |
| 2019-03-31 | $0.07B | $-0.17B | -253.03% |
| 2018-12-31 | $0.06B | $-0.17B | -281.97% |
| 2018-09-30 | $0.20B | $-0.02B | -10.66% |
| 2018-06-30 | $0.18B | $-0.03B | -19.10% |
| 2018-03-31 | $0.16B | $-0.03B | -19.88% |
| 2017-12-31 | $0.16B | $-0.02B | -12.66% |
| 2017-09-30 | $0.01B | $-0.16B | -1463.64% |
| 2017-06-30 | $0.01B | $-0.15B | -1233.33% |
| 2017-03-31 | $0.09B | $-0.07B | -73.63% |
| 2016-12-31 | $0.09B | $-0.06B | -64.13% |
| 2016-09-30 | $0.10B | $-0.05B | -54.74% |
| 2016-06-30 | $0.11B | $-0.03B | -30.84% |
| 2016-03-31 | $0.03B | $-0.09B | -284.85% |
| 2015-12-31 | $0.10B | $-0.02B | -18.81% |
| 2015-09-30 | $0.10B | $-0.01B | -10.20% |
| 2015-06-30 | $0.10B | $0.00B | 0.99% |
| 2015-03-31 | $0.10B | $0.01B | 9.71% |
| 2014-12-31 | $0.05B | $-0.04B | -80.85% |
| 2014-09-30 | $0.06B | $-0.02B | -28.07% |
| 2014-06-30 | $0.06B | $-0.01B | -20.34% |
| 2014-03-31 | $0.06B | 0 | 0.00% |
| 2013-12-31 | $0.06B | 0 | 0.00% |
| 2013-06-30 | $0.04B | $-0.00B | -7.69% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.263B | $0.059B |
| MacroGenics Inc. is a biopharmaceutical company. It is focused on discovering and developing innovative monoclonal antibody-based therapeutics. The Company has a diverse portfolio of product candidates focused in three therapeutic areas: oncology, autoimmune disorders and infectious diseases. MacroGenics Inc. is headquartered in Rockville, Maryland. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $178.017B | 23.31 |
| Stryker (SYK) | United States | $126.483B | 30.29 |
| Boston Scientific (BSX) | United States | $111.661B | 35.56 |
| EssilorLuxottica (ESLOY) | France | $99.732B | 0.00 |
| Medtronic (MDT) | Ireland | $98.953B | 14.81 |
| Lonza Group Ag (LZAGY) | Switzerland | $41.070B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.630B | 28.20 |
| ResMed (RMD) | United States | $27.824B | 26.12 |
| Terumo (TRUMY) | Japan | $24.790B | 35.01 |
| Koninklijke Philips (PHG) | Netherlands | $23.594B | 18.73 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.927B | 14.01 |
| Baxter (BAX) | United States | $16.898B | 12.01 |
| Insulet (PODD) | United States | $13.778B | 61.09 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.986B | 0.00 |
| Demant (WILYY) | Denmark | $9.175B | 0.00 |
| BellRing Brands (BRBR) | United States | $7.709B | 36.26 |
| Bio-Rad Laboratories (BIO) | United States | $7.704B | 25.19 |
| Lantheus Holdings (LNTH) | United States | $5.515B | 13.74 |
| Haemonetics (HAE) | United States | $4.287B | 21.14 |
| GN Store Nord (GNNDY) | Denmark | $4.205B | 23.62 |
| Perrigo (PRGO) | Ireland | $3.570B | 10.82 |
| Prestige Consumer Healthcare (PBH) | United States | $3.360B | 15.99 |
| Neogen (NEOG) | United States | $3.295B | 31.69 |
| TG Therapeutics (TGTX) | United States | $2.904B | 81.70 |
| ICU Medical (ICUI) | United States | $2.875B | 25.37 |
| Envista Holdings (NVST) | United States | $2.800B | 11.55 |
| Green Thumb Industries (GTBIF) | United States | $2.467B | 48.29 |
| Agios Pharmaceuticals (AGIO) | United States | $2.386B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.077B | 11.53 |
| LeMaitre Vascular (LMAT) | United States | $1.825B | 53.49 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.761B | 0.00 |
| Warby Parker (WRBY) | United States | $1.609B | 0.00 |
| InMode (INMD) | Israel | $1.468B | 7.80 |
| Verano Holdings (VRNOF) | United States | $1.292B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.292B | 9.60 |
| AtriCure (ATRC) | United States | $1.068B | 0.00 |
| Owens & Minor (OMI) | United States | $1.003B | 8.74 |
| National Vision Holdings (EYE) | United States | $0.977B | 31.08 |
| BioLife Solutions (BLFS) | United States | $0.923B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.791B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.694B | 14.78 |
| Evolus (EOLS) | United States | $0.688B | 0.00 |
| PetIQ (PETQ) | United States | $0.672B | 21.73 |
| Surmodics (SRDX) | United States | $0.599B | 37.48 |
| VAREX IMAGING (VREX) | United States | $0.587B | 13.81 |
| ZimVie (ZIMV) | United States | $0.506B | 43.16 |
| Valneva SE (VALN) | France | $0.501B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.495B | 0.00 |
| Quanterix (QTRX) | United States | $0.479B | 0.00 |
| Biote (BTMD) | United States | $0.459B | 10.57 |
| Jin Medical (ZJYL) | China | $0.438B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.394B | 0.00 |
| Cerus (CERS) | United States | $0.318B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.298B | 9.60 |
| Zynex (ZYXI) | United States | $0.283B | 38.78 |
| Aurora Cannabis (ACB) | Canada | $0.267B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.256B | 25.39 |
| Sanara MedTech (SMTI) | United States | $0.238B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.234B | 14.75 |
| Omeros (OMER) | United States | $0.225B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.220B | 0.00 |
| High Tide (HITI) | Canada | $0.171B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.165B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.154B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.150B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.140B | 19.89 |
| Veru (VERU) | United States | $0.134B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.130B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.114B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.103B | 0.00 |
| Fonar (FONR) | United States | $0.102B | 10.29 |
| Brainsway (BWAY) | Israel | $0.099B | 0.00 |
| InterCure (INCR) | Israel | $0.097B | 16.31 |
| Cellectar Biosciences (CLRB) | United States | $0.089B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.071B | 4.66 |
| MariMed (MRMD) | United States | $0.071B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.060B | 0.00 |
| Safety Shot (SHOT) | United States | $0.055B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.054B | 0.00 |
| Bright Green (BGXX) | United States | $0.050B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.049B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.047B | 0.00 |
| Apyx Medical (APYX) | United States | $0.046B | 0.00 |
| Modular Medical (MODD) | United States | $0.046B | 0.00 |
| United-Guardian (UG) | United States | $0.044B | 15.97 |
| ImmuCell (ICCC) | United States | $0.033B | 0.00 |
| Exagen (XGN) | United States | $0.031B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.022B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.016B | 0.00 |
| Agape ATP (ATPC) | $0.015B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.011B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.006B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.000B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |